Acta Pharmaceutica Sinica B
|
2026, 16(2): 1173-1174
• Corrections •
Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415]
Full
Yinying Pu1, Shaorong Huang2, Shuang Gao3, Yangying Duan1, Wenhao Li1, Qiyue Li1, Han Lin4, Kun Zhang1, Min Zhou3, Wencheng Wu1
Affiliations
1 Central Laboratory and Department of Medical Ultrasound, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, China;
2 Institute of Geriatrics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China;
3 Digestive Endoscopy Center, Shanghai Fourth People's Hospital to Tongji University, Shanghai 200081, China;
4 Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China
doi: 10.1016/j.apsb.2025.12.001
Outline
Yinying Pu, Shaorong Huang, Shuang Gao, Yangying Duan, Wenhao Li, Qiyue Li, Han Lin, Kun Zhang, Min Zhou, Wencheng Wu.
Author correction to “Cerium single-atom catalysts-armed Lactobacillus reuteri for multipronged anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease” [Acta Pharmaceutica Sinica B 15 (2025) 5400-5415][J].
Acta Pharmaceutica Sinica B,
2026
, 16
(2)
: 1173
-1174
.
DOI: 10.1016/j.apsb.2025.12.001
Year 2026 volume 16 Issue 2
PDF
8
5
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.12.001